3-179199807-A-T

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO8_SupportingB3_Supporting

The NM_006218.4(PIK3CA):c.470A>T (p.Asn157Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene PIK3CA is a known oncogene (CancerMine: 3 TSG, 156 oncogene, 103 driver citations). The gene PIK3CA is a cancer driver gene (CancerMine: 3 TSG, 156 oncogene, 103 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.N157D: Uncertain_significance (ClinVar VariationId 4861898, 1 star); p.N157S: Uncertain_significance (ClinVar VariationId 580643, 1 star)

Frequency

Genomes: not found (cov: 32)

Consequence

PIK3CA
NM_006218.4 missense

Scores

2
17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.86

Publications

1 publications found
Variant links:
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
PIK3CA Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia
  • megalencephaly-capillary malformation-polymicrogyria syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • vascular malformation
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006218.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 6.15 (threshold ≥3.09 for constraint)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_006218.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

PIK3CA NM_006218.4
MANE Select
HGVSc / HGVSpc.470A>Tp.Asn157Ile
Exon rankExon 3 of 21
missense
Prot: NP_006209.2UniProt: P42336

Ensembl Transcripts

PIK3CA ENST00000263967.4
TSL:2MANE Select
HGVSc / HGVSpc.470A>Tp.Asn157Ile
Exon rankExon 3 of 21
missense
Prot: ENSP00000263967.3UniProt: P42336
PIK3CA ENST00000955190.1
HGVSc / HGVSpc.470A>Tp.Asn157Ile
Exon rankExon 3 of 21
missense
Prot: ENSP00000625249.1UniProt: A0ACI8UU87
PIK3CA ENST00000876545.1
HGVSc / HGVSpc.470A>Tp.Asn157Ile
Exon rankExon 4 of 22
missense
Prot: ENSP00000546604.1UniProt: P42336

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic21
AlphaMissense
Benign0.14
BayesDel_addAF
Uncertain0.019T
BayesDel_noAF
Benign-0.21
CADD
Benign21
DANN
Benign0.96
DEOGEN2
Benign0.29T
Eigen
Benign-0.14
Eigen_PC
Benign0.095
FATHMM_MKL
Benign0.70D
FuncVEP CTI
Benign0.032
GPN-Star LLR
N/A-9.6
GPN-Star score
N/A9.6
LIST_S2
Uncertain0.93D
M_CAP
Benign0.019T
MetaRNN
Benign0.20T
MetaSVM
Benign-0.85T
Mutation Taster
N/A77/23polymorphism
MutationAssessor
Benign0.69N
PhyloP100
Benign2.9
popEVE
Benign-3.8
PrimateAI
Benign0.48T
PROVEAN
Benign-0.87N
REVEL
Benign0.17
Sift
Benign0.19T
Sift4G
Benign0.19T
Varity_R
N/A0.37
VESM-3B
Benign-5.6
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.